Plasma lipopolysaccharide levels predict mortality in acutely ill children in Low- and Middle-Income Countries

Chris A D Allen1, Arya Ghate1, James M Njunge2,3

  • 1Translational Gastroenterology Unit, University of Oxford, Oxford, UK.

Nature Communications
|November 28, 2025
PubMed

Insights

High levels of bacterial lipopolysaccharides (LPS) in the blood are linked to increased mortality in hospitalized children in low-resource areas. This association persists regardless of malnutrition, highlighting LPS as a critical indicator of disease severity.

Area of Science:

  • Global Health
  • Pediatrics
  • Immunology

Background:

  • Childhood mortality remains a critical issue in low-resource settings, often exacerbated by environmental enteric dysfunction (EED).
  • Bacterial lipopolysaccharides (LPS) in peripheral blood are recognized biomarkers for intestinal barrier dysfunction and inflammation.
  • The direct impact of LPS translocation on mortality in vulnerable pediatric populations has not been thoroughly investigated.

Purpose of the Study:

  • To investigate the association between plasma LPS levels and 90-day mortality in acutely ill hospitalized children.
  • To explore the relationship between LPS, EED biomarkers, and systemic inflammation in relation to mortality outcomes.
  • To identify potential molecular pathways and cellular interactions involved in LPS-mediated mortality.

Main Methods:

  • A nested case-cohort study involving 638 hospitalized children and 251 healthy controls across sub-Saharan Africa and South Asia.
  • Measurement of plasma LPS, inflammatory biomarkers (fecal calprotectin, myeloperoxidase, CD14), and nutritional markers.
  • Analysis of enteric microbiota, systemic inflammatory proteins, and gene expression profiles (single-cell transcriptomics) in non-survivors.

Main Results:

  • Elevated plasma LPS levels were significantly associated with increased 90-day mortality, independent of wasting status.
  • Non-survivors exhibited higher levels of gram-negative enteric microbiota, EED biomarkers, and systemic inflammatory proteins.
  • Differential gene expression in non-survivors implicated the Insulin-like growth factor (IGF) axis, Interleukin-1, and collagen regeneration pathways.

Conclusions:

  • Plasma LPS is a significant predictor of mortality in acutely ill children in low-resource settings, even in the absence of wasting.
  • The findings suggest a complex interplay between gut barrier dysfunction, systemic inflammation, and host response pathways contributing to mortality.
  • Identifying these pathways offers potential targets for therapeutic interventions to reduce childhood mortality in EED-endemic regions.